Circulating Tumor Cell (CTC) Testing Market by Technology, Enrichment, Application, End-user and Geography. Market Leaders are Fluxion Biosciences, Clearbridge BioMedics, Adnagen, Advanced Cell Diagnostics, Cynvenio Biosystems, Aviva Biosciences, Biocept,

Precision Business Insights (PBI) in its report titled “Circulating Tumor Cell Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2024” assesses the market performance over six years forecast period from 2019 to 2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The circulating tumor cell treatment market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2024. Due to high mortality rate caused by metastatic spread of cancer cells, urgent demand in finding new biomarkers which could detect early formation of cancer, led to an increased use of this testing. It provides a new insights for clinical management of cancer. However, identification of CTC requires innovative and challenging technology, which might hinder its growth in the developing countries.

Circulating tumor cell testing market segmented on the basis of application, technology, end user, and region.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/

CTC Enrichment Segment Expected to Dominate the Market

Based on technology type, the circulating tumor cell market is segmented as CTC enrichment, CTC detection, combined enrichment and separation of CTC. CTC enrichment technology segment has been witnessed to account for major revenue share over the forecast period. Its critical capacity for disease interrogation and target therapy, leads to rise in growth of demand for enrichment technology.

Hospital and Diagnostic Center Will Dominate the Revenue Share.

Based on end-user type, circulating tumor cell treatment market segmented into hospitals, research and academic institutes, diagnostic centers, and others. The hospital and diagnostic centers are witnessed to account for major revenue share over the forecast period.

Download free sample report at https://bit.ly/2FrdRfZ

North America, Accounts for Major Revenue Share for Circulating Tumor Cell Testing Market

Precision Business Insights (PBI) circulating tumor cell treatment market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share owing to its aging population, better regulations and government support. Asia Pacific is expected to dominate in the forecast period with increased CAGR due to rising healthcare expenditure in India, China, & Japan. Government initiative for awareness of cancer, R&D investments, and large patient pool.

Patent Grant & New Strategy Accelerate Circulating Tumor Cell Testing Market

Market players are focusing on the development of novel products and patents grants to introduce new prodyucts into the market. For instance, In April 2018, Natera, a company involved in non-invasive genetic testing and analysis of circulating cell-DNA, to present successful results of Signatera to monitor colorectal cancer and identify disease recurrence. In March 2018, Biocept Inc, received patent for its target selector assays for molecular analysis to improve the patient diagnosis with cancer in China.
Key player’s profiles in the report are Advanced Cell Diagnostics, Inc, ApoCell, Aviva Biosciences, Biocept Inc, Cynvenio Biosystems, Inc, Clearbridge Biomedics Pvt Ltd, Creatv Micreo Tech, Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen.

Detailed Segmentation

By Application Type

o Clinical
o Research
o Drug Development

By End-User Type

o Hospitals
o Research Labs
o Diagnostic Centers

By Technology Type

o CTC Enrichment
o CTC Detection
o Combined Enrichment and Separation of CTC

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Saudi Arabia
 Rest of MEA

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.